Acute Disseminated Encephalomyelitis (ADEM) – NORD Patient Overview
NORD's comprehensive patient-facing overview of ADEM covers symptoms, causes, diagnosis, treatment options, and support resources for patients and families affected by this rare autoimmune brain condition.
About This Resource
Acute Disseminated Encephalomyelitis (ADEM) is a rare, often post-infectious autoimmune condition in which the immune system attacks the myelin sheath, the protective coating around nerve fibers in the brain and spinal cord. It can occur after a viral illness or, rarely, after vaccination, and it most commonly affects children, though adults are not immune. For patients and families suddenly dealing with a frightening neurological crisis, clear and trustworthy information is critically important.
The National Organization for Rare Disorders (NORD) has produced a detailed, patient-friendly overview of ADEM that stands out for its medical accuracy and accessibility. The page explains what ADEM is, how it differs from multiple sclerosis and other demyelinating diseases, what symptoms to expect, and how the condition is typically diagnosed through MRI imaging and clinical evaluation.
The treatment section describes the standard-of-care approaches. High-dose corticosteroids are typically first-line, and IVIG and plasma exchange are used for refractory cases. The overview also addresses prognosis: while most patients recover well with treatment, some are left with lasting neurological deficits, and a small proportion may experience recurrent episodes.
NORD's page is particularly valuable for families because it explains the condition in language that does not require a medical degree, while still providing enough clinical detail to support meaningful conversations with neurologists. Links to additional resources and related organizations are included, making it a useful launching point for newly diagnosed patients and caregivers navigating an unfamiliar diagnosis.
As a leading rare disease patient organization in the United States, NORD is one of the most reliable sources for rare disease information available. Their ADEM overview is free, up-to-date, and requires no registration to access, making it an ideal first stop for anyone touched by this diagnosis.